Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
320
-
Total 13F shares, excl. options
-
53,225,671
-
Shares change
-
+2,318,899
-
Total reported value, excl. options
-
$8,544,993,638
-
Value change
-
+$384,771,818
-
Put/Call ratio
-
72%
-
Number of buys
-
166
-
Number of sells
-
-158
-
Price
-
$160.56
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2014
389 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q3 2014.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 320 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53,225,671 shares
.
Largest 10 shareholders include FMR LLC (8,650,367 shares), PUTNAM INVESTMENTS LLC (7,873,483 shares), VANGUARD GROUP INC (3,268,413 shares), JANUS CAPITAL MANAGEMENT LLC (3,188,130 shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1,996,359 shares), LONE PINE CAPITAL LLC (1,788,607 shares), WELLS FARGO & COMPANY/MN (1,762,020 shares), BlackRock Institutional Trust Company, N.A. (1,424,374 shares), Westpac Banking Corp (1,392,130 shares), and BlackRock Fund Advisors (1,314,863 shares).
This table shows the top 320 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.